File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.5414/CNP86S199
- WOS: WOS:000944265900001
- Find via
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Article: ESRD: epidemiology and treatment in developing countries in Southeast Asia
Title | ESRD: epidemiology and treatment in developing countries in Southeast Asia |
---|---|
Authors | |
Keywords | end-stage renal disease Southeast Asia epidemiology renal replacement therapy Thailand Philippines Cambodia Brunei |
Issue Date | 2016 |
Publisher | Dustri-Verlag Dr. Karl Feistle. The Journal's web site is located at http://www.clinnephrol.com |
Citation | Clinical Nephrology, 2016, 86, n. suppl. 1, p. S136-S139 How to Cite? |
Abstract | Southeast Asia generally is understood to include the countries of Brunei, Cambodia, East Timor, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam. Nine of these 11 sovereign states are categorized to have low-to-middle income by the World Bank. Like other regions of the world, the provision of renal replacement therapy (RRT) in developing economies in South-East Asia is limited by the lack of financial and other resources. The number of nephrologists in most of these countries remains low. While some countries have well developed registries of ESRD treatment, data are completely unknown in others. Here, an appraisal of the status of ESRD from only 4 South-East Asia countries is presented. |
Persistent Identifier | http://hdl.handle.net/10722/247544 |
ISSN | 2023 Impact Factor: 1.1 2023 SCImago Journal Rankings: 0.373 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tang, SCW | - |
dc.date.accessioned | 2017-10-18T08:28:56Z | - |
dc.date.available | 2017-10-18T08:28:56Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Clinical Nephrology, 2016, 86, n. suppl. 1, p. S136-S139 | - |
dc.identifier.issn | 0301-0430 | - |
dc.identifier.uri | http://hdl.handle.net/10722/247544 | - |
dc.description.abstract | Southeast Asia generally is understood to include the countries of Brunei, Cambodia, East Timor, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam. Nine of these 11 sovereign states are categorized to have low-to-middle income by the World Bank. Like other regions of the world, the provision of renal replacement therapy (RRT) in developing economies in South-East Asia is limited by the lack of financial and other resources. The number of nephrologists in most of these countries remains low. While some countries have well developed registries of ESRD treatment, data are completely unknown in others. Here, an appraisal of the status of ESRD from only 4 South-East Asia countries is presented. | - |
dc.language | eng | - |
dc.publisher | Dustri-Verlag Dr. Karl Feistle. The Journal's web site is located at http://www.clinnephrol.com | - |
dc.relation.ispartof | Clinical Nephrology | - |
dc.subject | end-stage renal disease | - |
dc.subject | Southeast Asia | - |
dc.subject | epidemiology | - |
dc.subject | renal replacement therapy | - |
dc.subject | Thailand | - |
dc.subject | Philippines | - |
dc.subject | Cambodia | - |
dc.subject | Brunei | - |
dc.title | ESRD: epidemiology and treatment in developing countries in Southeast Asia | - |
dc.type | Article | - |
dc.identifier.email | Tang, SCW: scwtang@hku.hk | - |
dc.identifier.authority | Tang, SCW=rp00480 | - |
dc.identifier.doi | 10.5414/CNP86S199 | - |
dc.identifier.hkuros | 282329 | - |
dc.identifier.volume | 2017 | - |
dc.identifier.volume | 86 | - |
dc.identifier.issue | suppl. 1 | - |
dc.identifier.spage | S136 | - |
dc.identifier.epage | S139 | - |
dc.identifier.isi | WOS:000944265900001 | - |
dc.publisher.place | München-Deisenhofen, Germany | - |
dc.customcontrol.immutable | csl 200323 | - |
dc.identifier.issnl | 0301-0430 | - |